Pathophysiology of obesity: Why surgery remains the most effective treatment

被引:20
作者
Waseem, Talat
Mogensen, Kris M.
Lautz, David B.
Robinson, Malcolm K.
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Program Weight Management, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg,Metabol Support Serv, Boston, MA 02115 USA
关键词
obesity; bariatric surgery; Roux-en-Y gastric bypass; appetite; gut-brain axis; ghrelin; leptin; PYY3-36;
D O I
10.1007/s11695-007-9220-1
中图分类号
R61 [外科手术学];
学科分类号
摘要
Obesity is a rapidly increasing, worldwide epidemic. Despite recent scientific advances, no currently recommended dietary program or medication results in long-term weight loss of more than 10% of body weight for the vast majority of people who attempt these interventions. Hence, surgical intervention is recommended for patients with a BMI >= 40 kg/m(2). Although surgery is an effective, sustainable treatment of obesity, it can be associated with potentially significant perioperative risks and long-term complications. Current research is focused on developing a medical therapy, which produces more effective and sustainable weight loss, yet avoids the risks inherent in major surgery. With a reduced risk profile, such therapy could also be appropriately offered to those who are less obese and, in theory, help those who have BMIs as low as 27 kg/m(2). Toward 1hat end, numerous scientists are working to both unravel the pathophysiology of obesity and to determine why surgical intervention is so effective. This review briefly examines the current status of obesity pathophysiology and management, the reasons for failure of conventional medical treatments, and the success' of surgical intervention. Finally, future areas of research are discussed.
引用
收藏
页码:1389 / 1398
页数:10
相关论文
共 80 条
[1]   Plasma ghrelin concentratin in the short-term following biliopancreatic diversion [J].
Adami, GF ;
Cordera, R ;
Marinari, G ;
Lamerini, G ;
Andraghetti, G ;
Scopinaro, N .
OBESITY SURGERY, 2003, 13 (06) :889-892
[2]   To work in the garden of god -: The Swedish Nursing Association and the concept of the calling, 1909-1933 [J].
Andersson, Å .
NURSING HISTORY REVIEW, 2002, 10 :3-19
[3]   Antagonism of ghrelin receptor reduces food intake and body weight gain in mice [J].
Asakawa, A ;
Inui, A ;
Kaga, T ;
Katsuura, G ;
Fujimiya, M ;
Fujino, MA ;
Kasuga, M .
GUT, 2003, 52 (07) :947-952
[4]   Inhibition of food intake in obese subjects by peptide YY3-36 [J].
Batterham, RL ;
Cohen, MA ;
Ellis, SM ;
Le Roux, CW ;
Withers, DJ ;
Frost, GS ;
Ghatei, MA ;
Bloom, SR .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (10) :941-948
[5]   Current and investigational antiobesity agents and obesity therapeutic treatment targets [J].
Bays, HE .
OBESITY RESEARCH, 2004, 12 (08) :1197-1211
[6]   A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity [J].
Bray, GA ;
Hollander, P ;
Klein, S ;
Kushner, R ;
Levy, B ;
Fitchet, M ;
Perry, BH .
OBESITY RESEARCH, 2003, 11 (06) :722-733
[7]   Bariatric surgery and long-term control of morbid obesity [J].
Brolin, RE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (22) :2793-2796
[8]   Evolution of operative procedures for the management of morbid obesity 1950-2000 [J].
Buchwald, H ;
Buchwald, JN .
OBESITY SURGERY, 2002, 12 (05) :705-717
[9]   Pre- and post-prandial plasma ghrelin levels do not correlate with satiety or failure to achieve a successful outcome after Roux-en-Y gastric bypass [J].
Christou, NV ;
Look, D ;
McLean, AP .
OBESITY SURGERY, 2005, 15 (07) :1017-1023
[10]   Ghrelin levels and sleeve gastrectomy in super-super-obesity [J].
Cohen, R ;
Uzzan, B ;
Bihan, H ;
Khochtali, I ;
Reach, G ;
Catheline, JM .
OBESITY SURGERY, 2005, 15 (10) :1501-1502